1. Home
  2. REPL vs WNC Comparison

REPL vs WNC Comparison

Compare REPL & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • WNC
  • Stock Information
  • Founded
  • REPL 2015
  • WNC 1985
  • Country
  • REPL United States
  • WNC United States
  • Employees
  • REPL N/A
  • WNC N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • WNC Construction/Ag Equipment/Trucks
  • Sector
  • REPL Health Care
  • WNC Industrials
  • Exchange
  • REPL Nasdaq
  • WNC Nasdaq
  • Market Cap
  • REPL 816.4M
  • WNC 850.9M
  • IPO Year
  • REPL 2018
  • WNC 1991
  • Fundamental
  • Price
  • REPL $11.05
  • WNC $18.91
  • Analyst Decision
  • REPL Strong Buy
  • WNC Hold
  • Analyst Count
  • REPL 4
  • WNC 1
  • Target Price
  • REPL $17.00
  • WNC $18.00
  • AVG Volume (30 Days)
  • REPL 488.6K
  • WNC 500.9K
  • Earning Date
  • REPL 11-12-2024
  • WNC 10-24-2024
  • Dividend Yield
  • REPL N/A
  • WNC 1.69%
  • EPS Growth
  • REPL N/A
  • WNC N/A
  • EPS
  • REPL N/A
  • WNC N/A
  • Revenue
  • REPL N/A
  • WNC $2,126,025,999.00
  • Revenue This Year
  • REPL N/A
  • WNC N/A
  • Revenue Next Year
  • REPL $469.74
  • WNC N/A
  • P/E Ratio
  • REPL N/A
  • WNC N/A
  • Revenue Growth
  • REPL N/A
  • WNC N/A
  • 52 Week Low
  • REPL $4.92
  • WNC $15.94
  • 52 Week High
  • REPL $12.97
  • WNC $30.07
  • Technical
  • Relative Strength Index (RSI)
  • REPL 43.04
  • WNC 52.09
  • Support Level
  • REPL $10.57
  • WNC $18.15
  • Resistance Level
  • REPL $12.73
  • WNC $20.17
  • Average True Range (ATR)
  • REPL 0.67
  • WNC 0.55
  • MACD
  • REPL -0.16
  • WNC -0.02
  • Stochastic Oscillator
  • REPL 20.00
  • WNC 54.35

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The company's mission is to enable customers to succeed with breakthrough ideas and solutions that help them move everything from the first to the final mile. It designs and manufactures a diverse variety of products, including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: